Lang Ho Lee

7PUBLICATIONS
93CO-AUTHORS
Molecular targetsProteins and peptidesApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Hypersonic propulsion and hypersonic aerothermodynamicsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Apr 22, 2026
Targeting CRTC2 reverses STK11 mutant NSCLC tumor resistance to immunotherapy.

|Jun 09, 2025
Defining Non-small Cell Lung Cancer Tumor Microenvironment Changes at Primary and Acquired Immune Checkpoint Inhibitor Resistance Using Clinical and Real-World Data.

Lang Ho Lee, Xin Xu, Thanos Mourikis

|Oct 20, 2022
Proprotein Convertase Subtilisin/Kexin 9 (PCSK9) Promotes Macrophage Activation via LDL Receptor-Independent Mechanisms.

Shunsuke Katsuki, Prabhash K Jha, Adrien Lupieri

|Sep 21, 2022
Preclinical Characterization and Phase I Study of an Anti-HER2-TLR7 Immune-Stimulator Antibody Conjugate in Patients with HER2+ Malignancies.

Filip Janku, Sae-Won Han, Toshihiko Doi

|Feb 10, 2022
Second Heart Field-Derived Cells Contribute to Angiotensin II-Mediated Ascending Aortopathies.

Hisashi Sawada, Yuriko Katsumata, Hideyuki Higashi

|Nov 20, 2021
Phase I study of single agent NIZ985, a recombinant heterodimeric IL-15 agonist, in adult patients with metastatic or unresectable solid tumors.

Kevin Conlon, Dionysios C Watson, Thomas A Waldmann

Pageof 2

Frequent Collaborators

3 joint publications

Sasha A Singh

2 joint publications

Carlotta Costa

2 joint publications

Joel Wagner

2 joint publications

Arda Halu